Records containing: Type 2 Diabetes Mellitus
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-09-20REAL HEALTH-Diabetes: Reach Ahead for Lifestyle and Health-Diabetes
-
CLINICAL_TRIALS study record update · 2021-09-17Memory Advancement by Intranasal Insulin in Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2021-09-13Evaluation of an mHealth Behavioural Intervention for the Self-Management for Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2021-09-05A Comparative Interventional Study to Evaluate the Role of LRYGBP, LSG and SMM in Patients of Type II DM and BMI Between 27.5 - 32.5 kg / m²."
-
CLINICAL_TRIALS study record update · 2021-09-01The Clinical Study of the Effect of Highland Barley Diet on Blood Glucose in Patients With Type 2 Diabetes Mellitus
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-08-25Metabolic Effects of Melatonin Treatment
-
CLINICAL_TRIALS study record update · 2021-08-25A Randomized, Open-label, Single Dose, Crossover Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-398 in Healthy Volunteers Under Fasting Conditions
-
CLINICAL_TRIALS study record update · 2021-08-16A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
-
CLINICAL_TRIALS study record update · 2021-08-10A Cluster Randomized Trial to Investigate the Impact of a Type 2 Diabetes Risk Prediction Model on Change in Physical Activity Within Routine Health Checks in Primary Care.
-
CLINICAL_TRIALS study record update · 2021-07-27A Randomized, Double-blind, Placebo and Active Comparator-Controlled, Parallel-Group Study of the Efficacy and Safety of Rivoglitazone as Monotherapy Treatment of Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2021-07-26Contribution of Substance P to Blood Pressure Regulation in the Setting of Dipeptidyl Peptidase IV (DPP4) and Angiotensin-Converting Enzyme (ACE) Inhibition
-
CLINICAL_TRIALS study record update · 2021-07-09Prevalence of Cardiovascular Disease in Swedish Patients With Type 2 Diabetes and in Patients Initiating on Empagliflozin
-
CLINICAL_TRIALS study record update · 2021-07-07A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events
-
CLINICAL_TRIALS study record update · 2021-06-30Renal and Cardiovascular Effect of Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibition in Combination With Loop Diuretics in Diabetic Patients With Chronic Heart Failure
-
CLINICAL_TRIALS study record update · 2021-06-29Optimizing Lifestyle Interventions With Mindfulness-based Strategies in Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2021-06-28The Relationship of Advanced Glycation Endproducts in the Anterior Lens Capsule to Glycemic Status and Diabetic Retinopathy: A Cross Sectional Study of Patients With and Without Type 2 Diabetes Mellitus Undergoing Cataract Surgery
-
CLINICAL_TRIALS study record update · 2021-06-28A Multicenter, Randomized, Double-blind, Parallel Controlled Phase III Clinical Trial of DBRP108 in Combination With Metformin Hydrochloride in the Treatment of Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2021-06-25A Randomized, Double-blind, Placebo-controlled, 3-arm, Parallel-group 52-week Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin in Patients With Type 2 Diabetes Mellitus and Severe Renal Impairment Who Have Inadequate Glycemic Control
-
CLINICAL_TRIALS study record update · 2021-06-25A 26-week Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study With a 78-week Extension Period to Evaluate the Efficacy and Bone Safety of Sotagliflozin in Patients 55 Years or Older With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
-
CLINICAL_TRIALS study record update · 2021-06-25A Randomized, Double-blind, Placebo-controlled, 3-arm, Parallel-group 52-week Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin in Patients With Type 2 Diabetes Mellitus and Moderate Renal Impairment Who Have Inadequate Glycemic Control
-
CLINICAL_TRIALS study record update · 2021-06-21A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin as Monotherapy in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control
-
CLINICAL_TRIALS study record update · 2021-06-18Effects of Low Carbohydrate Diet (LCBD) on Weight and Renal Outcome in Patients With Diabetic Kidney Disease (DKD)- A Pilot Study
-
CLINICAL_TRIALS study record update · 2021-06-18A 24-Week, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Effects of Saxagliptin and Sitagliptin in Patients With Type 2 Diabetes Mellitus and Heart Failure
-
CLINICAL_TRIALS study record update · 2021-06-16Fasting and Postprandial Cerebral Blood Flow in Type 2 Diabetic Patients
-
CLINICAL_TRIALS study record update · 2021-06-15A Phase 2, Double-blind Dose Escalation Regimen of Once-Weekly OPK-88003 in Subjects With Type 2 Diabetes